Wishlist
Add items to wish list
Add items to comparison
0
Add products to cart

Mounjaro KwikPen 5 mg

In stock
SKU: Mounjaro KwikPen 5 мг
$692
Sign in
to add this item to wishlist
%
Sign in to see your personal discount
Quick order
Features
Country  USA
Description

Mounjaro KwikPen 5 mg

An Innovative Approach to Sugar and Weight Management

Mounjaro KwikPen is a modern, next-generation medication based on tirzepatide, recognized as a breakthrough in the treatment of type 2 diabetes and effective weight management. It combines high clinical efficacy with ease of use and is aimed at comprehensively improving metabolic processes in the body.
Mounjaro's unique mechanism of action lies in its dual mechanism of action—simultaneous action on the GIP and GLP-1 receptors, providing a pronounced blood sugar-lowering effect, improved insulin sensitivity, and appetite suppression.

 

Tirzepatide Mechanism of Action

Mounjaro (tirzepatide) is an agonist of the following receptors:

• glucose-dependent insulinotropic polypeptide (GIP);
• glucagon-like peptide-1 (GLP-1).


Thanks to its dual action, Mounjaro:

• stimulates insulin production in response to elevated glucose levels;
• improves tissue sensitivity to insulin, reducing insulin resistance;
• suppresses glucagon secretion, preventing sharp fluctuations in blood sugar;
• slows gastric emptying;
• regulates appetite and promotes weight loss by acting on the satiety centers in the brain.

 

Ease of use

Mounjaro is available as a KwikPen syringe pen for subcutaneous injection once a week, making therapy as comfortable as possible.


Advantages of the KwikPen:

• simple and accurate dosing;
• gradual and stable release of the active ingredient;
• increased patient adherence to treatment;
• suitable for self-administration.

 

Advantages of Mounjaro KwikPen

• effective reduction of blood glucose levels;
• increased insulin sensitivity;
• assistance in weight management and weight loss;
• Improved metabolic parameters;
• Reduced risk of complications of type 2 diabetes;
• Convenient once-weekly administration.

 

Who is Mounjaro suitable for?

Mounjaro may be recommended for:

• Patients with type 2 diabetes;
• People with insulin resistance and metabolic syndrome;
• Overweight patients (as prescribed by a doctor);
• Those who need comprehensive improvement of carbohydrate metabolism.

A new review or comment
Sign in with
Rate this item